Regulus Therapeutics (NASDAQ:RGLS) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a report issued on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on RGLS. SVB Leerink assumed coverage on Regulus Therapeutics in a research report on Monday, March […]

Related Keywords

United States , Leerink Partnrs , Prelude Capital Management , Dimensional Fund Advisors , Canaccord Genuity Group , Wells Fargo Company , Regulus Therapeutics Inc , Renaissance Technologies , Commonwealth Equity Services , Blackrock Inc , Regulus Therapeutics Company Profile , Regulus Therapeutics , Free Report , Genuity Group , Wells Fargo , Moderate Buy , Therapeutics Trading Down , Get Free Report , Fund Advisors , Equity Services , Capital Management , Therapeutics Inc , Regulus Therapeutics Daily ,